Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer.

Saved in:
Bibliographic Details
Title: Intraperitoneal nivolumab for malignant ascites in patients with advanced gastrointestinal or pancreaticobiliary tract cancer.
Authors: Wang HT; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan.; Institute of Translational Medicine and New Drug Development, China Medical University, Taichung, 406040, Taiwan., Yu YL; Institute of Translational Medicine and New Drug Development, China Medical University, Taichung, 406040, Taiwan.; Graduate Institute of Biomedical Sciences, China Medical University, Taichung, 406040, Taiwan.; Center for Molecular Medicine, China Medical University Hospital, Taichung, 404327, Taiwan.; Department of Medical Laboratory Science and Biotechnology, Asia University, Taichung, 413305, Taiwan., Lo WJ; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan., Lin MC; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan., Chu CL; Cancer Center, China Medical University Hospital, Taichung, 404327, Taiwan., Chen CY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan., Wang ST; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan., Chiu CF; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan.; Cancer Center, China Medical University Hospital, Taichung, 404327, Taiwan.; College of Medicine, School of Medicine, China Medical University, Taichung, 406404, Taiwan., Bai EJ; Bachelor of Science in Kinesiology, Exercise Science, The University of Texas at Austin, Austin, TX, 78712, USA., Bai LY; Division of Hematology and Oncology, Department of Internal Medicine, China Medical University Hospital, 2, Yude road, North district, Taichung, 404327, Taiwan. lybai6@gmail.com.; College of Medicine, School of Medicine, China Medical University, Taichung, 406404, Taiwan. lybai6@gmail.com.
Source: International journal of clinical oncology [Int J Clin Oncol] 2026 Feb; Vol. 31 (2), pp. 281-291. Date of Electronic Publication: 2025 Dec 10.
Publication Type: Clinical Trial; Journal Article
Journal Info: Publisher: Springer-Verlag Tokyo Country of Publication: Japan NLM ID: 9616295 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1437-7772 (Electronic) Linking ISSN: 13419625 NLM ISO Abbreviation: Int J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:1437-7772
DOI:10.1007/s10147-025-02930-y